BRIEF published on 08/01/2025 at 14:05, 9 months 4 days ago CARMAT: Resumption of Quotation and Update on Judicial Recovery Takeover Offer CARMAT Resumption Of Quotation Judicial Recovery Aeson® Artificial Heart
BRIEF published on 07/01/2025 at 20:50, 10 months 4 days ago Half-yearly report on CARMAT's liquidity contract Liquidity Contract Actions CARMAT Judicial Recovery Stockbroker
BRIEF published on 06/20/2025 at 19:15, 10 months 15 days ago CARMAT launches a donation campaign in the face of a financial crisis Funding Heart Failure Artificial Heart Financial Crisis Donation Campaign
PRESS RELEASE published on 06/20/2025 at 19:10, 10 months 15 days ago Inside Information / Other news releases CARMAT launches a donation campaign to address critical financial situation and risk of insolvency. The initiative aims to secure urgent funding for its innovative total artificial heart Financial Situation CARMAT Artificial Heart Donation Campaign Risk Of Insolvency
BRIEF published on 06/04/2025 at 17:50, 11 months 1 day ago CARMAT: Terms and conditions for the General Meeting of June 26, 2025 General Assembly Remote Voting CARMAT Artificial Heart Financial Risks
BRIEF published on 06/02/2025 at 07:05, 11 months 3 days ago CARMAT makes its first sales of artificial hearts in Israel CARMAT European Union Israel Aeson® Locations
BRIEF published on 04/09/2025 at 17:50, 1 year ago CARMAT Achieves Strong Q1 2025 Results CARMAT Q1 2025 FDA Discussions Aeson® Implants EFICAS Trial
PRESS RELEASE published on 04/09/2025 at 17:45, 1 year ago Inside Information / Other news releases CARMAT delivers strong Q1 2025 results with €2.4m sales, progresses EFICAS trial, and advances FDA discussions for EFS study in the US. Aiming for long-term patient support with enhanced heart by end of 2025 CARMAT Long-term Support FDA Discussions Q1 2025 Results EFICAS Trial
BRIEF published on 02/17/2025 at 07:05, 1 year 2 months ago CARMAT's Aeson® Artificial Heart: Promising Results for Heart Failure with Pulmonary Hypertension Medical Innovation Heart Failure Treatment Aeson® Artificial Heart Pulmonary Hypertension Transplant Eligibility
PRESS RELEASE published on 02/17/2025 at 07:00, 1 year 2 months ago Inside Information / Other news releases CARMAT's Aeson® total artificial heart, featured in The Journal of Heart and Lung Transplantation, offers a promising solution for heart failure patients with pulmonary hypertension, potentially becoming a standard treatment Heart Failure CARMAT Aeson® Pulmonary Hypertension Transplant
Published on 05/05/2026 at 22:10, 40 minutes ago International Battery Metals LTD. to Present at The Sidoti Micro Cap Conference
Published on 05/05/2026 at 22:00, 50 minutes ago Rocky Shore Closes Acquisition of Additional Mining Claims
Published on 05/05/2026 at 18:10, 4 hours 40 minutes ago Silver Spruce Resources Inc. Provides an Update On Jackie and Diamante Projects
Published on 05/05/2026 at 22:07, 43 minutes ago Kaufman & Broad SA: DIVIDEND PAYMENT IN RESPECT OF THE FINANCIAL YEAR ENDED NOVEMBER 30, 2025
Published on 05/05/2026 at 21:56, 53 minutes ago Kaufman & Broad SA: DESCRIPTION OF THE SHARE REPURCHASE PROGRAM OF 2026, MAY 5
Published on 05/05/2026 at 21:36, 1 hour 14 minutes ago Kaufman & Broad SA: ORDINARY AND EXTRAORDINARY SHAREHOLDERS’MEETING OF 2026, MAY 5
Published on 05/05/2026 at 18:30, 4 hours 20 minutes ago AEVIS VICTORIA SA - Infracore SA enters into a long-term lease with Kantonsspital Winterthur for the Privatklinik Lindberg building
Published on 05/05/2026 at 19:00, 3 hours 50 minutes ago Combined General Meeting of Air Liquide Shareholders of May 5, 2026
Published on 05/05/2026 at 18:03, 4 hours 47 minutes ago Aéroports de Paris SA - Shares and voting rights as of 30 April 2026
Published on 05/05/2026 at 17:53, 4 hours 56 minutes ago TF1 - Monthly disclosure of the total number of shares and voting rights - April 2026
